- Home
- ZNTL vs PTMN Comparison
ZNTL vs PTMN Comparison
Compare ZNTL & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- PTMN
- Stock Information
- Founded
- ZNTL 2014
- PTMN 2006
- Country
- ZNTL United States
- PTMN United States
- Employees
- ZNTL N/A
- PTMN N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- PTMN Finance: Consumer Services
- Sector
- ZNTL Health Care
- PTMN Finance
- Exchange
- ZNTL Nasdaq
- PTMN Nasdaq
- Market Cap
- ZNTL 105.8M
- PTMN 107.9M
- IPO Year
- ZNTL 2020
- PTMN N/A
- Fundamental
- Price
- ZNTL $1.24
- PTMN $12.62
- Analyst Decision
- ZNTL Buy
- PTMN Hold
- Analyst Count
- ZNTL 7
- PTMN 1
- Target Price
- ZNTL $8.60
- PTMN $14.00
- AVG Volume (30 Days)
- ZNTL 1.4M
- PTMN 39.6K
- Earning Date
- ZNTL 08-08-2025
- PTMN 08-07-2025
- Dividend Yield
- ZNTL N/A
- PTMN 15.53%
- EPS Growth
- ZNTL N/A
- PTMN N/A
- EPS
- ZNTL N/A
- PTMN N/A
- Revenue
- ZNTL $26,865,000.00
- PTMN $58,024,000.00
- Revenue This Year
- ZNTL N/A
- PTMN N/A
- Revenue Next Year
- ZNTL N/A
- PTMN $12.20
- P/E Ratio
- ZNTL N/A
- PTMN N/A
- Revenue Growth
- ZNTL N/A
- PTMN N/A
- 52 Week Low
- ZNTL $1.01
- PTMN $11.48
- 52 Week High
- ZNTL $5.44
- PTMN $19.95
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.75
- PTMN 56.93
- Support Level
- ZNTL $1.31
- PTMN $12.45
- Resistance Level
- ZNTL $1.39
- PTMN $12.72
- Average True Range (ATR)
- ZNTL 0.11
- PTMN 0.25
- MACD
- ZNTL -0.03
- PTMN 0.09
- Stochastic Oscillator
- ZNTL 8.91
- PTMN 81.10
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About PTMN Portman Ridge Finance Corporation
Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.